Unlock the full potential of your preclinical oncology studies


With an attrition rate of up to 95% for oncology drug development, it is evident that significant barriers still exist when it comes to translating preclinical investigation findings to in-human trials.

This new Guide from TransCure bioServices explores how humanized mouse models can help accelerate the successful development of novel, safe, and effective treatments for oncology by generating human-relevant data.

We examine:

  • The types of mouse model available
  • The role and application of humanized mouse models in immuno-oncology research
  • How to select the most appropriate model for your specific needs
  • The benefits of partnering with a preclinical CRO specialising in humanized mouse models

Download the Guide now.


Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free